Circadian Rhythms: Mechanisms and Therapeutic Implications
Tóm tắt
The mammalian circadian system is organized in a hierarchical manner in that a central pacemaker in the suprachiasmatic nucleus (SCN) of the brain's hypothalamus synchronizes cellular circadian oscillators in most peripheral body cells. Fasting-feeding cycles accompanying rest-activity rhythms are the major timing cues in the synchronization of many, if not most, peripheral clocks, suggesting that the temporal coordination of metabolism and proliferation is a major task of the mammalian timing system. The inactivation of noxious food components by hepatic, intestinal, and renal detoxification systems is among the metabolic processes regulated in a circadian manner, with the understanding of the involved clock output pathways emerging. The rhythmic control of xenobiotic detoxification provides the molecular basis for the dosing time-dependence of drug toxicities and efficacy. This knowledge can in turn be used in improving or designing chronotherapeutics for the patients who suffer from many of the major human diseases.
Từ khóa
Tài liệu tham khảo
Redfern P. 2003.Chronotherapeutics. London: Pharmaceutical Press. 426 pp.
Labrecque G, Beauchamp D. 2003. Rhythms and pharmacokinetics. See Ref. 24, Ch. 4, pp.75–110
Lévi F, 2003, Fluoropyrimidines in Cancer Therapy, 107
Granda TG, 2001, Cancer Res., 61, 1996
Boughattas NA, 1989, Cancer Res., 49, 3362
Filipski E, 1999, J. Pharmacol. Exp. Ther, 289, 231
Ohdo S, 2000, J. Pharmacol. Exp. Ther., 294, 488
Blumenthal RD, 2001, Clin. Cancer Res, 7, 3178
Sothern RB, 1988, Ann. Rev. Chronopharmacol, 5, 385
Labrecque G, 2003, Chronopharmacologie. Rythmes Biologiques et Administration des Médicaments
Reinberg A, 1984, Ann. Rev. Chronopharmacol, 1, 61
Decousus H, 1986, Ann. Rev. Chronopharmacol., 3, 321
Petit E, 1988, Cancer Res, 48, 1676
Focan C, 1989, Bull. Cancer, 76, 909
Boissier C, Decousus H, Perpoint B, Ollagnier M, Mismetti P, et al. 1990.Ann. Rev. Chronopharmacol.Vol 7, pp289–92. Oxford:Pergamon Press
Witte K, Lemmer B. 2003. Rhythms and pharmacodynamics. See Ref. 24, Ch. 5, pp.111–26
Levi F, 1988, Exp. Hematol, 16, 696
Perpoint B, 1995, Exp. Hematol., 23, 362
Gonzalez FJ, 1998, Drug Metab. Dispos, 26, 1194
Falvey E, 1996, Biol. Chem, 377, 797
Lévi F, 1984, Ann. Rev. Chronopharmacol., 1, 345
De Vita V, 1993, Cancer. Principles and Practice of Oncology, 4
Zhang R, 1993, Cancer Res, 53, 2816
Harris BE, 1990, Cancer Res, 50, 197
Hecquet B, 1985, Cancer Treat. Rep, 69, 79
Iurisci I, Filipski E, Reinhardt J, Bach S, Gianella-Borradori A, et al. 2006. Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor.Cancer Res.In press
Bruguerolle B, 1989, Prog. Clin. Biol. Res, 300, 199